Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...

The Symplicity studies suggest that intravascular renal sympathetic nervous denervation improves blood pressure in patients with resistant hypertension, thus potentially opening a market for ...

The United States Food and Drug Administration, in 2023, approved renal denervation—a catheter-based procedure that ablates the renal sympathetic nerves—as an adjunctive treatment for patients ...

2025年1月15日， 盈康生命 旗下四川友谊医院心血管内科介入团队成功为一名长期受难治性高血压困扰的患者实施RDN（经导管肾交感神经消融）手术，这标志着医院首例经导管去肾动脉交感神经术、高血压微创介入手术成功完成，难治性高血压的临床服务能力再上新台阶。

Furthermore, as there is no evidence of benefit of renal denervation in poorly compliant patients, drug adherence should be evaluated using validated questionnaires or, preferably, dosage of drug ...

近日，中山大学附属第一医院心血管医学部完成了全国首批经皮导管肾动脉去交感神经消融术（Renal denervation，RDN），为1名中青年难治性高血压患者进行了RDN降压治疗。这位受困于高血压病10余年、曾服用5种降压药、已出现靶器官损害的患者，有望在术后少吃药甚至不吃药。此次手术的成功开展，标志着中山一院在高血压防治领域正式迈进微创介入手术治疗的新时代。 01/ 一次手术有望实现长期降压 微 ...

Just hours earlier, the Centers for Medicare and Medicaid Services (CMS) had informed the company that it was opening a national coverage analysis of renal denervation and a final decision will be ...

It’s not a cure – and some patients get no benefit. But Garasic said multiple studies show on average an 8 to 10-point drop in blood pressure, a modest but important improvement. Some like Garrity see ...

Nothing doctors prescribed controlled Michael Garrity’s dangerously high blood pressure — until they zapped away some nerves ...

On Monday, the Centers for Medicare & Medicaid Services (CMS) initiated a national coverage analysis of renal denervation for the treatment of uncontrolled hypertension. Medtronic, which sparked the ...